{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T19:32:08Z","timestamp":1766259128670,"version":"3.48.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,20]]},"DOI":"10.7759\/cureus.99722","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T19:29:27Z","timestamp":1766258967000},"source":"Crossref","is-referenced-by-count":0,"title":["Bridging Gaps in Hepatitis Delta Virus Care: A Cross-Sectional Mixed-Methods Study of Clinician Perspectives From Major Urban Centers in Pakistan"],"prefix":"10.7759","author":[{"given":"Saeed","family":"Hamid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Munawar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaigham","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghias Un Nabi","family":"Tayyab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rao Saad Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asher Bin","family":"Feroze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad K","family":"Niaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao Z","year":"2020","unstructured":"Miao Z, Zhang S, Ou X, et al.. Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection. J Infect Dis. 2020, 221:1677-87. 10.1093\/infdis\/jiz633","journal-title":"J Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020533","article-title":"Hepatitis virus and hepatocellular carcinoma: recent advances","volume":"15","author":"Shen C","year":"2023","unstructured":"Shen C, Jiang X, Li M, Luo Y. Hepatitis virus and hepatocellular carcinoma: recent advances. Cancers (Basel). 2023, 15:10.3390\/cancers15020533","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10018-1172","article-title":"Viral hepatitis in Pakistan: past, present, and future","volume":"6","author":"Butt AS","year":"2016","unstructured":"Butt AS, Sharif F. Viral hepatitis in Pakistan: past, present, and future. Euroasian J Hepatogastroenterol. 2016, 6:70-81. 10.5005\/jp-journals-10018-1172","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.29309\/TPMJ\/2024.31.02.7870","article-title":"Hepatitis D seroprevalence: an alarming situation and war without weapon","volume":"7","author":"Bhutto AR","year":"2024","unstructured":"Bhutto AR, Abbasi A, Rafi S, et al.. Hepatitis D seroprevalence: an alarming situation and war without weapon. Profs Med Jr. 2024, 7:176-82. 10.29309\/TPMJ\/2024.31.02.7870","journal-title":"Profs Med Jr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.17582\/journal.pjz\/20210930100952","article-title":"Frequency of hepatitis D viral infection in chronic hepatitis B patients in Pakistan","author":"Afzal S","year":"2022","unstructured":"Afzal S, Ahmad J, Amin I, et al.. Frequency of hepatitis D viral infection in chronic hepatitis B patients in Pakistan. Pakistan J Zool. 2022, 1-4. 10.17582\/journal.pjz\/20210930100952","journal-title":"Pakistan J Zool"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.47391\/JPMA.20194","article-title":"Viral hepatitis in Pakistan; a global concern","volume":"74","author":"Ishaq MU","year":"2024","unstructured":"Ishaq MU, Rasheed F. Viral hepatitis in Pakistan; a global concern. J Pak Med Assoc. 2024, 74:1391. 10.47391\/JPMA.20194","journal-title":"J Pak Med Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002810","article-title":"Multiple barriers impede screening for hepatitis delta: an Internet-based survey of healthcare providers","volume":"119","author":"Rao S","year":"2024","unstructured":"Rao S, Qazi S, Lee D, et al.. Multiple barriers impede screening for hepatitis delta: an Internet-based survey of healthcare providers. Am J Gastroenterol. 2024, 119:2126-9. 10.14309\/ajg.0000000000002810","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01117-4","article-title":"Identifying barriers to hepatitis B and delta screening, prevention, and linkage to care among people who use drugs in Philadelphia, Pennsylvania, USA","volume":"21","author":"Zovich B","year":"2024","unstructured":"Zovich B, Freeland C, Moore H, et al.. Identifying barriers to hepatitis B and delta screening, prevention, and linkage to care among people who use drugs in Philadelphia, Pennsylvania, USA. Harm Reduct J. 2024, 21:199. 10.1186\/s12954-024-01117-4","journal-title":"Harm Reduct J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2019.0048","article-title":"Characterization of hepatitis delta virus among pregnant women of Pakistan","volume":"32","author":"Aftab M","year":"2019","unstructured":"Aftab M, Naz S, Aftab B, et al.. Characterization of hepatitis delta virus among pregnant women of Pakistan. Viral Immunol. 2019, 32:335-40. 10.1089\/vim.2019.0048","journal-title":"Viral Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21763\/tjfmpc.528253","article-title":"HBV and HDV seroprevalence among healthy people admitted for hepatitis B vaccination","volume":"13","author":"Rahman AS","year":"2019","unstructured":"Rahman AS, Amir M, Siddiqui MA, et al.. HBV and HDV seroprevalence among healthy people admitted for hepatitis B vaccination. Tur Jr Fam Med Pri Car. 2019, 13:60-6. 10.21763\/tjfmpc.528253","journal-title":"Tur Jr Fam Med Pri Car"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.07.021","article-title":"Addressing bias and improving research on gender and racial disparities in hepatitis B assessment and treatment","volume":"81","author":"Wang Y","year":"2024","unstructured":"Wang Y, Guo X, Yuan Y. Addressing bias and improving research on gender and racial disparities in hepatitis B assessment and treatment. J Hepatol. 2024, 81:e279-80. 10.1016\/j.jhep.2024.07.021","journal-title":"J Hepatol"},{"key":"ref12","unstructured":"World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. (2024). Accessed: June 8, 2025: https:\/\/www.who.int\/publications\/i\/item\/9789240090903."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-021-00693-2","article-title":"The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?","volume":"79","author":"Hayashi T","year":"2021","unstructured":"Hayashi T, Takeshita Y, Hutin YJ, et al.. The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?. Arch Public Health. 2021, 79:180. 10.1186\/s13690-021-00693-2","journal-title":"Arch Public Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000663","article-title":"HDV RNA and liver disease progression: what do we know?","volume":"79","author":"Stockdale AJ","year":"2024","unstructured":"Stockdale AJ, Degasperi E. HDV RNA and liver disease progression: what do we know?. Hepatology. 2024, 79:983-5. 10.1097\/HEP.0000000000000663","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10855","article-title":"The severity of hepatitis D in young adults of age 18-25 years","volume":"12","author":"Abbas Z","year":"2020","unstructured":"Abbas Z, Qadeer MA, Mandviwalla HA, Abbas M. The severity of hepatitis D in young adults of age 18-25 years. Cureus. 2020, 12:e10855. 10.7759\/cureus.10855","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15579","article-title":"Elimination of HDV: Epidemiologic implications and public health perspectives","volume":"43 Suppl 1","author":"Tharwani A","year":"2023","unstructured":"Tharwani A, Hamid S. Elimination of HDV: Epidemiologic implications and public health perspectives. Liver Int. 2023, 43 Suppl 1:101-7. 10.1111\/liv.15579","journal-title":"Liver Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL clinical practice guidelines on hepatitis delta virus","volume":"79","author":"European Association for the Study of the Liver","year":"2023","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on hepatitis delta virus. J Hepatol. 2023, 79:433-60. 10.1016\/j.jhep.2023.05.001","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-023-07960-y","article-title":"Diagnosis and management of hepatitis delta virus infection","volume":"68","author":"Pan C","year":"2023","unstructured":"Pan C, Gish R, Jacobson IM, et al.. Diagnosis and management of hepatitis delta virus infection. Dig Dis Sci. 2023, 68:3237-48. 10.1007\/s10620-023-07960-y","journal-title":"Dig Dis Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.sjg_322_24","article-title":"Multisociety consensus recommendations on hepatitis delta virus infection","volume":"31","author":"Alqahtani SA","year":"2025","unstructured":"Alqahtani SA, Sanai FM, Banama MA, et al.. Multisociety consensus recommendations on hepatitis delta virus infection. Saudi J Gastroenterol. 2025, 31:5-13. 10.4103\/sjg.sjg_322_24","journal-title":"Saudi J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213429","article-title":"A phase 3, randomized trial of bulevirtide in chronic hepatitis D","volume":"389","author":"Wedemeyer H","year":"2023","unstructured":"Wedemeyer H, Aleman S, Brunetto MR, et al.. A phase 3, randomized trial of bulevirtide in chronic hepatitis D. N Engl J Med. 2023, 389:22-32. 10.1056\/NEJMoa2213429","journal-title":"N Engl J Med"},{"key":"ref21","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. (2016). Accessed: December 20, 2025: https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/apt.18446","article-title":"Editorial: Hepatitis D screening-DAS (delta virus awareness and screening) approach in primary care","volume":"61","author":"Singh N","year":"2025","unstructured":"Singh N, Ma M. Editorial: Hepatitis D screening-DAS (delta virus awareness and screening) approach in primary care. Aliment Pharmacol Ther. 2025, 61:723-4. 10.1111\/apt.18446","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/443810-bridging-gaps-in-hepatitis-delta-virus-care-a-cross-sectional-mixed-methods-study-of-clinician-perspectives-from-major-urban-centers-in-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T19:29:28Z","timestamp":1766258968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/443810-bridging-gaps-in-hepatitis-delta-virus-care-a-cross-sectional-mixed-methods-study-of-clinician-perspectives-from-major-urban-centers-in-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.99722","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,20]]}}}